BSX241122P77000
- 0.22
- 0.000.00%
Boston Scientific Newsroom
Optimistic Buy Rating for Boston Scientific Driven by Promising WATCHMAN FLX Trial Results
Boston Scientific Reports Outcomes From Trial of LAAC Device
Express News | Boston Scientific Watchman Flx™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the Option Clinical Trial
Boston Scientific WATCHMAN FLX Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial
News On Axonics Inc. (AXNX) Now Under BSX
Weekly Buzz: Not All Parties Last Forever
Market Falls to End All-Time High Week | Wall Street Today
Boston Scientific Corporation (BSX) UBS Global Healthcare Conference (Transcript)
Boston Scientific Put Volume Heavy and Directionally Bearish
Market Falls Friday After Light Earnings and 13F's | Live Stock
Boston Scientific Closes Acquisition of Axonics, Inc.
Market Falls Thursday, Powell Said Fed Will Take Things Slow | Wall Street Today
Express News | Viking Global: Change in Holdings Are as at Qtr-Ended Sept 30 Vs Qtr-Ended June 30
Express News | Viking Global Investors LP Cuts Share Stake in T-Mobile US Inc by 53.8% to 1.2 Mln Shares
Express News | Viking Global Investors LP Reports Share Stake of 967.2 Thousand Shares in Boston Scientific Corp
Axonics Gains After Nasdaq Delisting Notice for Sale to Boston Scientific
Thursday Market Chills From Election Celebration | Live Stock
Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock
MYGN Stock Might Gain From SneakPeek Availability in Retail Stores
IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant